Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

WITHDRAWN: Etidronate for treating and preventing postmenopausal osteoporosis.

Cranney A, Adachi JD, Griffith L, Guyatt G, Krolicki N, Robinson VA, Shea BJ, Wells G.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD003376. Review.

PMID:
17636719
2.

Etidronate for treating and preventing postmenopausal osteoporosis.

Cranney A, Welch V, Adachi JD, Guyatt G, Krolicki N, Griffith L, Shea B, Tugwell P, Wells G.

Cochrane Database Syst Rev. 2001;(4):CD003376. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD003376. Cochrane Database Syst Rev. 2008;(1):CD003376.

PMID:
11687195
3.

A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.

Cranney A, Guyatt G, Krolicki N, Welch V, Griffith L, Adachi JD, Shea B, Tugwell P, Wells G; Osteoporosis Research Advisory Group (ORAG).

Osteoporos Int. 2001;12(2):140-51.

PMID:
11303715
4.

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD004523.

PMID:
17636764
5.

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G.

Cochrane Database Syst Rev. 2003;(4):CD004523. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD004523.

PMID:
14584020
6.

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003376. doi: 10.1002/14651858.CD003376.pub3. Review.

PMID:
18254018
7.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
8.

WITHDRAWN: Calcium supplementation on bone loss in postmenopausal women.

Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Hamel C, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group; Osteoporosis Research Advisory Group.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004526. Review.

PMID:
17636765
9.

Calcium supplementation on bone loss in postmenopausal women.

Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Hamel C, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group; Osteoporosis Research Advisory Group.

Cochrane Database Syst Rev. 2004;(1):CD004526. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD004526.

PMID:
14974070
10.

Calcium supplementation on bone loss in postmenopausal women.

Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Hamel C, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group; Osteoporosis Research Advisory Group.

Cochrane Database Syst Rev. 2003;(4):CD004526. Review. Update in: Cochrane Database Syst Rev. 2004;(1):CD004526.

PMID:
14584022
11.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005326. Review.

PMID:
17054253
12.
13.

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004523. doi: 10.1002/14651858.CD004523.pub3. Review.

PMID:
18254053
14.

Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis.

Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group.

Endocr Rev. 2002 Aug;23(4):517-23. Review.

PMID:
12202466
15.

Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis.

Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Shea B, Wells G, Adachi J, Waldegger L, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group.

Endocr Rev. 2002 Aug;23(4):540-51. Review.

PMID:
12202469
17.

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.

Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC 3rd, Yanover MJ, et al.

N Engl J Med. 1990 Jul 12;323(2):73-9.

18.

Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women.

Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N, Cranney A, Adachi J, Tugwell P, Josse R, Greenwood C, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group.

Endocr Rev. 2002 Aug;23(4):560-9. Review.

PMID:
12202471
19.

A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.

Adachi JD, Roux C, Pitt PI, Cooper C, Moniz C, Dequeker J, Ioannidis G, Cawley MI, Jenkins EA, Walker-Bone KE, Pack S, Stephenson GF, Laan RF, Brown J, Geusens P.

J Rheumatol. 2000 Oct;27(10):2424-31.

PMID:
11036840

Supplemental Content

Support Center